Maternal #HIV Exposure Is Associated With Transient Transcriptional Changes in Monocytes and Natural Killer Cells in Early Infancy academic.oup.com/jid/advance-... (open access) @jidjournal.bsky.social

Alimatravir Oral Once Monthly in Adults With Low Likelihood of #HIV Exposure: A Randomized, Double-Blind, Placebo-Controlled Study academic.oup.com/jid/advance-... (open access) @jidjournal.bsky.social

Spatial Constraints Limit Natural Killer Cell Access to Germinal Centre #HIV Reservoirs in Lymph Nodes academic.oup.com/jid/advance-... (open access) @jidjournal.bsky.social

Trotz des weit verbreiteten Wissens um die Bedeutung von U = U in der #HIV-Community bestehe weiterhin eine Kluft zwischen dem Verständnis der wissenschaftlichen Erkenntnisse und deren Umsetzung in die Praxis, und zwar selbst im Gesundheitswesen. (2)
 www.poz.com/article/viiv...

“Many encounter HIV stigma and ageism at the same time. Black people, LGBTQ+ people, women, transgender people, and people living in poverty often carry additional burdens created by discrimination and unequal access to care.” – Malcolm Reid

@glaad.bsky.social

#HIV

glaad.org/op-ed-living...

The structure constrained the design. Experiments constrained the models.
7 months later, what left that loop is a preclinical candidate against #HIV entry at MPER, ready for the next studies.
The rest — potency in the right models, a path through development — is still ahead.

Read more:

Most #HIV drugs stop the virus after it is already inside the cell. A small molecule that stops it at the door is a different bet, and a harder one.
Viva-Thera, which we incubated, has nominated a preclinical candidate against that entry machinery in 7 months.
The target: MPER

⏳ Just 1 week left to apply!

The IAS CIPHER Research Grant Programme offers up to USD 140,000 over 2 years for early-stage #investigators in low- and middle-income countries working on #paediatric & adolescent #HIV.

📅 Deadline: 30 Sep, 18:00 CEST

Learn more & apply 👇

The Scientific Programme for #HIVGlasgow2026 is now live!

Explore four days of cutting-edge science and expert insights on the latest advances in HIV prevention, treatment and care.

📍 Glasgow | 8–11 Nov 2026
🔗 hivglasgow.org/programme

#HIV #HIVResearch

Timely HIV treatment response is crucial.
🕒 72.2% returned to clinics within 6 months
📉 85% on TLD resuppressed vs. 58.2% on TLE
🔄 27.9% TLD switched regimen vs. 66.6% TLE
#HIV #TLD #TLE
https://tnyp.me/QriA7fax/s

🇹🇷 Fiji'de HIV nedeniyle OHAL ilan edildi

#Türkiye #Haber #Gündem #Fiji #OHAL #HIV #GazetePencere

The FDA has approved a new once-daily pill that could make HIV treatment easier for some people living with the virus.

Find out more: https://bit.ly/4h8EWoY

#HIV #HIVTreatment #FDA #Bixlenvo #Gilead #GileadSciences #lgbtqnews #gaynews #gayhealth #LGBTQHealth #HIVCare

🇹🇷 Fiji'de HIV/AIDS nedeniyle olağanüstü hâl ilan edildi

#Türkiye #Haber #Gündem #Fiji #HIV #AIDS #DWTürkçe #Dünya

📹 Click below to watch our interview from #2026USCHA featuring 3 experts discussing their Rx for Change program, which is integrating community pharmacies into the #HIV prevention landscape to address access and stigma across the Southern US. #IDSky #HealthDisparities

@emoryrollins.bsky.social

Happening Tomorrow 🔽

🔗 Register: avac.org/event/evolvi...

#PrEP #HIVprevention #HIV

Nach den Razzien gegen #LGBTIQ+ -Organisationen in der Türkei sind offenbar einige Menschen mit #HIV in Isolationshaft, so die NGO Pozitif Alan (Positive Space). Pozitif Alan fordert, dass ihnen der ununterbrochene Zugang zu Medikamenten und Behandlung gewährleistet wird.

A question on #HIV/AIDS #Drugs tabled by Lord Doyle on 16-09-2026 has been answered by Baroness Merron. https://questions-statements.parliament.uk/written-questions/detail/2026-09-16/HL3611

Live from Brighton: James, our Senior Policy Manager, has had a great few days at #LDConf

Including meeting with @mpsusanmurray.bsky.social to share our joint manifesto with @waverleycare.bsky.social & @tht.org.uk on the action needed to end new #HIV transmissions in Scotland by 2030.